• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Meet the Board: Perry Cohen of The Pharmacy Group Discusses PBMs, COVID Responses in U.S. and Other Countries

Podcast

In this episode of Tuning In to the C-Suite's Meet the Board series, MHE Senior Editor Peter Wehrwein and Associate Editor Briana Contreras speak with Perry Cohen, Pharm. D., CEO of The Pharmacy Group. Perry has been on MHE's Editorial Advisory Board for over 25 years and has contributed a number of interviews and guest articles toward the publication. In this discussion, Briana, Peter and Perry talked about the current pharmacy benefits market as well as Sweden, Japan and the United States' response to COVID-19.

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.

Perry Cohen, Pharm. D

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.